Detection of antisynthetase syndrome in patients with idiopathic interstitial pneumonias

Respiratory Medicine

Volumn 105, Issue 8, 2011, Pages 1238-1247

  Watanabe, Kizuku ^a   Handa, Tomohiro ^a,b   Tanizawa, Kiminobu ^a   Hosono, Yuji ^a   Taguchi, Yoshio ^c   Noma, Satoshi ^c   Kobashi, Yoichiro ^c   Kubo, Takeshi ^a   Aihara, Kensaku ^a   Chin, Kazuo ^a   Nagai, Sonoko ^d   Mimori, Tsuneyo ^a   Mishima, Michiaki ^a  

^a KYOTO UNIVERSITY   (Japan)

^b KYOTO UNIVERSITY HOSPITAL   (Japan)

^c TENRI HOSPITAL   (Japan)

^d Clinical Research Center   (Japan)

Author keywords

Aminoacyl tRNA synthetase; Antisynthetase syndrome; Idiopathic interstitial pneumonia; Nonspecific interstitial pneumonia

Indexed keywords

ANTIBODY;

ADULT; AGED; ANTIBODY SCREENING; ANTISYNTHETASE SYNDROME; ARTICLE; BRONCHIECTASIS; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; INTERSTITIAL PNEUMONIA; LYMPH FOLLICLE; MALE; ONSET AGE; PREVALENCE; PRIORITY JOURNAL; RETROSPECTIVE STUDY;

ADULT; AMINO ACYL-TRNA SYNTHETASES; AUTOANTIBODIES; AUTOIMMUNE DISEASES; FEMALE; HUMANS; LUNG DISEASES, INTERSTITIAL; MALE; MIDDLE AGED; MYOSITIS; PRECIPITIN TESTS; RETROSPECTIVE STUDIES; RNA, TRANSFER;

EID: 79959263591     PISSN: 09546111     EISSN: 15323064     Source Type: Journal    
DOI: 10.1016/j.rmed.2011.03.022     Document Type: Article

References (39)

1. American Thoracic Society/European respiratory Society International Multidisciplinary consensus classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med 2002;165:277-304.
2. Antoniou KM, Margaritopoulos G, Economidou F, Siafakas NM. Pivotal clinical dilemmas in collagen vascular diseases associated with interstitial lung involvement. Eur Respir J 2009;33:882-96.
3. Mimori T, Imura Y, Nakashima R, Yoshifuji H. Autoantibodies in idiopathic inflammatory myopathy: an update on clinical and pathophysiological significance. Curr Opin Rheumatol 2007;19:523-9. (Pubitemid 47530870)
4. Targoff IN. Autoantibodies in polymyositis. Rheum Dis Clin North Am 1992;18:455-82.
5. Love LA, Leff RL, Fraser DD, Targoff IN, Dalakas M, Plotz PH, et al. A new approach to the classification of idiopathic inflammatory myopathy: myositis-specific autoantibodies define useful homogeneous patient groups. Medicine 1991;70:360-74.
6. Marie I, Hachulla E, Chérin P, Dominique S, Hatron PY, Hellot MF, et al. Interstitial lung disease in polymyositis and dermatomyositis. Arthritis Rheum 2002;47:614-22. (Pubitemid 35461314)
7. Yoshifuji H, Fujii T, Kobayashi S, Imura Y, Fujita Y, Kawabata D, et al. Anti-aminoacyl-tRNA synthetase antibodies in clinical course prediction of interstitial lung disease complicated with idiopathic inflammatory myopathies. Autoimmunity 2006;39:233-41. (Pubitemid 43879036)
8. Fischer A, Swigris JJ, du Bois RM, Lynch DA, Downey GP, Cosgrove GP, et al. Anti-synthetase syndrome in ANA and anti-Jo-1 negative patients presenting with idiopathic interstitial pneumonia. Respir Med 2009;103:1719-24.
9. Frank CA, Steven ME, Daniel AB, Dennis JM, James FF, Norman SC, et al. The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
10. Eng MT, Alan SC, James FF, Alfonse TM, Dennis JM, Naomi FR, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25:1271-7.
11. Vitali C, Moutsopoulos HM, Bombardieri S. The European Community Study Group on diagnostic criteria for Sjögren's syndrome. Sensitivity and specificity of tests for ocular and oral involvement in Sjögren's syndrome. Ann Rheum Dis 1994;53:637-47.
12. Alfonse TM. Subcommittee for scleroderma criteria of the american rheumatism association diagnostic and Therapeutic criteria C. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 1980;23:581-90.
13. Alarcon-Segovia D, Cardiel MH. Comparison between 3 diagnostic criteria for mixed connective tissue disease. Study of 593 patients. J Rheumatol 1989;16:328-34. (Pubitemid 19104571)
14. Savage COS, Winearls CG, Evans DJ, Rees AJ, Lockwood CM. Microscopic polyarteritis: presentation, pathology and prognosis. Q J Med 1985;56:467-83. (Pubitemid 16221674)
15. Leavitt RY, Fauci AS, Bloch DA, Michel BA, Hunder GG, Arend WP, et al. The American College of Rheumatology 1990 criteria for the classification of Wegener's granulomatosis. Arthritis Rheum 1990;33:1101-7.
16. Bohan A, Peter JB. Polymyositis and dermatomyositis - I, II. N Engl J Med 1975;292:344-7. 403-407.
17. Kinder BW, Collard HR, Koth L, Daikh DI, Wolters PJ, Elicker B, et al. Idiopathic nonspecific interstitial pneumonia: lung manifestation of undifferentiated connective tissue disease? Am J Respir Crit Care Med 2007;176:691-7.
18. Mino M, Noma S, Taguchi Y, Tomii K, Kohri Y, Oida K. Pulmonary involvement in polymyositis and dermatomyositis: sequential evaluation with CT. Am J Roentgenol 1997;169:83-7. (Pubitemid 27289614)
19. Hansell DM, Bankier AA, MacMahon H, McLoud TC, Müller NL, Remy J. Fleischner Society: Glossary of Terms for Thoracic Imaging1. Radiology 2008;246:697-722.
20. Travis WD, Hunninghake G, King Jr TE, Lynch DA, Colby TV, Galvin JR, et al. Idiopathic nonspecific interstitial pneumonia: report of an American Thoracic Society Project. Am J Respir Crit Care Med 2008;177:1338-47. (Pubitemid 351860911)
21. Park SG, Park HS, Jeong IK, Cho YM, Lee HK, Kang YS, et al. Autoantibodies against aminoacyl-tRNA synthetase: novel diagnostic marker for type 1 diabetes mellitus. Biomarkers 2010;15:358-66.
22. Hirakata M, Suwa A, Nagai S, Kron MA, Trieu EP, Mimori T, et al. Anti-KS: identification of autoantibodies to asparaginyl-transfer RNA synthetase associated with interstitial lung disease. J Immunol 1999;162:2315-20. (Pubitemid 29288856)
23. Marguerie C, Bunn CC, Beynon HL, Bernstein RM, Hughes JM, So AK, et al. Polymyositis, pulmonary fibrosis and autoantibodies to aminoacyl-tRNA synthetase enzymes. Q J Med 1990;77:1019-38. (Pubitemid 20370993)
24. Hirakata M, Mimori T, Akizuki M, Craft J, Hardin JA, Homma M. Autoantibodies to small nuclear and cytoplasmic ribonucleoproteins in Japanese patients with inflammatory muscle disease. Arthritis Rheum 1992;35:449-56.
25. Targoff IN, Trieu EP, Miller FW. Reaction of anti-OJ autoantibodies with components of the multi-enzyme complex of aminoacyl-tRNA synthetases in addition to isoleucyl-tRNA synthetase. J Clin Invest 1993;91:2556-64. (Pubitemid 23182509)
26. Ohosone Y, Ishida M, Takahashi Y, Matsumura M, Hirakata M, Kawahara Y, et al. Spectrum and clinical significance of autoantibodies against transfer RNA. Arthritis Rheum 1998;41:1625-31. (Pubitemid 28459921)
27. Friedman AW, Targoff IN, Arnett FC. Interstitial lung disease with autoantibodies against aminoacyl-tRNA synthetases in the absence of clinically apparent myositis. Semin Arthritis Rheum 1996;26:459-67. (Pubitemid 26274719)
28. Hirakata M, Suwa A, Takada T, Sato S, Nagai S, Genth E, et al. Clinical and immunogenetic features of patients with autoantibodies to asparaginyl-transfer RNA synthetase. Arthritis Rheum 2007;56:1295-303. (Pubitemid 46608655)
29. Sato S, Kuwana M, Hirakata M. Clinical characteristics of Japanese patients with anti-OJ (anti-isoleucyl-tRNA synthetase) autoantibodies. Rheumatology 2007;46:842-5. (Pubitemid 47061719)
30. Kalluri M, Sahn SA, Oddis CV, Gharib SL, Christopher-Stine L, Danoff SK, et al. Clinical profile of Anti-PL-12 autoantibody. Chest 2009;135:1550-6.
31. La Corte R, naco ALM, Locaputo A, Dolzani F, Trotta F. In patients with antisynthetase syndrome the occurrence of anti-Ro/SSA antibodies causes a more severe interstitial lung disease. Autoimmunity 2006;39:249-53.
32. Váncsa A, Csípo{combining double acute accent} I, Németh J, Dévényi K, Gergely L, Dankó K. Characteristics of interstitial lung disease in SS-A positive/Jo-1 positive inflammatory myopathy patients. Rheumatol Int 2009;29:989-94.
33. Tansey D, Wells AU, Colby TV, Ip S, Nikolakoupolou A, du Bois RM, et al. Variations in histological patterns of interstitial pneumonia between connective tissue disorders and their relationship to prognosis. Histopathology 2004;44:585-96.
34. Song JW, Do K-H, Kim M-Y, Jang SJ, Colby TV, Kim DS. Pathologic and Radiologic differences between idiopathic and collagen vascular disease-related usual interstitial pneumonia. Chest 2009;136:23-30.
35. Tanaka N, Kim JS, Newell JD, Brown KK, Cool CD, Meehan R, et al. Rheumatoid Arthritiserelated lung diseases: CT Findings1. Radiology 2004;232:81-91. (Pubitemid 38796446)
36. Doria A, Mosca M, Gambari PF, Bombardieri S. Defining unclassifiable connective tissue diseases: incomplete, undifferentiated, or both? J Rheumatol 2005;32:213-5. (Pubitemid 40209116)
37. Mosca M, Tani C, Bombardieri S. A case of undifferentiated connective tissue disease: is it a distinct clinical entity? Nat Clin Pract Rheumatol 2008;4:328-32.
38. Wilkes MR, Sereika SM, Fertig N, Lucas MR, Oddis CV. Treatment of antisynthetase-associated interstitial lung disease with tacrolimus. Arthritis Rheum 2005;52:2439-46. (Pubitemid 41117430)
39. Sauty A, Rochat T, Schoch OD, Hamacher J, Kurt AM, Dayer JM, et al. Pulmonary fibrosis with predominant CD8 lymphocytic alveolitis and anti-Jo-1 antibodies. Eur Respir J 1997;10:2907-12. (Pubitemid 28052811)